Molecular Characterization of Prostate Cancers in the Precision Medicine Era.

导出 OA

翻译打印收藏纠错

第一作者： Emilio Francesco,Giunta

第一单位： Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania "Luigi Vanvitelli", 80131 Naples, Italy.

作者： Emilio Francesco,Giunta ^[1] ; Laura,Annaratone ^[2] ; Enrico,Bollito ^[3] ; Francesco,Porpiglia ^[4] ; Matteo,Cereda ^[5] ; Giuseppe Luigi,Banna ^[6] ; Alessandra,Mosca ^[7] ; Caterina,Marchiò ^[8] ; Pasquale,Rescigno ^[9]

作者单位： Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania "Luigi Vanvitelli", 80131 Naples, Italy. ^[1] Department of Medical Sciences, University of Turin, 10126 Turin, Italy. ^[2] Pathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, 10060 Turin, Italy. ^[3] Department of Pathology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, 10043 Turin, Italy. ^[4] Department of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, 10043 Turin, Italy. ^[5] Cancer Genomics and Bioinformatics Unit, IIGM-Italian Institute for Genomic Medicine, c/o IRCCS Candiolo, 10060 Turin, Italy. ^[6] Candiolo Cancer Institute, FPO-IRCCS, Str. Prov.le 142, km 3.95, 10060 Candiolo, Italy. ^[7] Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth PO2 8QD, UK. ^[8] Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, 10060 Turin, Italy. ^[9] Interdisciplinary Group for Translational Research and Clinical Trials, Urological Cancers (GIRT-Uro), Candiolo Cancer Institute, FPO-IRCCS, Candiolo, 10060 Turin, Italy. ^[10]

关键词 PARP inhibitor immunotherapy liquid biopsy molecular oncology precision medicine predictive biomarkers prognostic biomarkers prostate cancer

DOI 10.3390/cancers13194771

PMID 34638258

发布时间 2023-09-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交